UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 59

of 'Treatment of chronic myeloid leukemia in chronic phase after failure of initial therapy'

59
TI
Four-year follow-up of patients with chronic-phase chronic myeloid leukemia (CP-CML) receiving 100 mg of dasatinib once daily
AU
Shah NP, Cortes JE, Schiffer CA, et al
SO
J Clin Oncol. 2010;28(15s):490s.
 
AD